Ma Z et al. (16), first identified the relevance between SNHG17 and tumor cell proliferation in colorectal cancer, and revealed that SNHG17 epigenetically targets p57 by binding to enhancers on zeste homolog 2 (EZH2). The gene discussed is EZH2; the disease is neoplasm.